InsiderTrades

Form 4 for CADL Candel Therapeutics, Inc.

Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-26 · accession 0001873919-24-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-12-30 2024-12-26+ CADL Aguilar Laura K. 10% D - Sale to Iss $8.93 -100.0K 223.5K -31% -$893.0K
MI 2024-12-30 2024-12-26+ CADL Aguilar Laura K. 10% D - Sale to Iss $8.93 -100.0K 131.4K -43% -$893.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common CADL 2024-12-27 D D 50,000 $8.85 173,512 D — —
2 Common CADL 2024-12-26 D D 50,000 $9.01 223,512 D By LKA 2022 Revocable Trust — — (F1) Shares of common stock held by spouse LKA 2022 Revocable trust
3 Common CADL 2024-12-26 D D 50,000 $9.01 181,443 I By LKA 2022 Revocable Trust — — (F1) Shares of common stock held by spouse LKA 2022 Revocable trust
4 Common CADL 2024-12-27 D D 50,000 $8.85 131,443 I — —